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Abstract Proinflammatory cytokines are essential mediators
and indicators of an inflammatory process occurring in the
body. Their physiological role is to stimulate the immune re-
sponse, yet their excessive propagation and interaction with
cells outside the immune system may be linked to the risk of
organ damage. This is specifically important in the case of
immature tissues of fetuses and prematurely born infants.
Analysis of the concentrations of specific cytokines in differ-
ent compartments makes it possible to assess the risk of pre-
mature birth, preterm rupture of the membranes, and to deter-
mine an existing intrauterine infection. The purpose of this
paper is to summarize the existing research concerning the
relationships between the concentrations of specific proin-
flammatory cytokines in different compartments (maternal
blood serum, amniotic fluid, umbilical cord blood, arterial
and venous blood, and cerebrospinal fluid of the newborn)
and the risk of intraventricular hemorrhage (IVH) and the
degree of its severity. The paper takes also into account the
assessment of the usefulness of cytokines as biomarkers for
IVH and its complications (posthemorrhagic hydrocephalus,
white matter injury).
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Dynamic development of perinatal medicine and neona-
tology has contributed to increased survival rates among
prematurely born infants, leading at the same time to a
relative increase in the number of multi-organ complica-
tions occurring in these babies. Intracranial, mainly intra-
ventricular hemorrhages (IVHs), resulting from the imma-
turity of brain structures, represent one of the most com-
mon pathologies in premature infants. The incidence of
this pathology is inversely proportional to gestational
age. There are four degrees of IVH severity, graded I–IV
[21]. Bleeding graded I and II is often self-limiting.
Higher grade hemorrhages result in higher risk of
neurodevelopmental delay; they are also the main cause
of cerebral palsy and increased perinatal mortality rates in
this group of infants [7, 20]. It is estimated that IVH
occurs in as much as 20% of infants born before 32nd
week of gestation [4].
The etiopathogenesis of IVH is complex. Besides gesta-
tional age (below 32 weeks) and body weight at birth (less
than 1500 g), there are also other IVH risk factors identified,
including absence of prenatal steroid therapy in women at risk
of premature delivery, early clamping of the umbilical cord
(less than 30 s after birth), symptoms of intrauterine infection
in the mother and the newborn, and labor and delivery com-
plicated by bleeding or perinatal hypoxia. The group of infants
with an elevated IVH risk includes also newborns with intra-
uterine growth retardation or those who in the first days of
their life were treated with crystalloids (bolus 10–15 ml/kg)
and/or catecholamins for hypotension and NaHCO3 for acido-
sis. IVH risk group includes also newborns with blood clotting
disorders, thrombocytopenia, hypoglycemia, pneumothorax,
lung bleeding, and those transported from another hospital
[2, 5]. Moreover, nowadays, an increasing attention is being
paid to genetic factors in the development of IVH; however, it
has only been confirmed by few studies so far.
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The purposes of the paper are to review and summarize the
results of studies to date concerning the impact of the concen-
tration of specific proinflammatory cytokines measured in the
mother, the fetus, and the newborn on the risk of IVH and to
discuss genetic factors whose involvement in IVH pathogen-
esis has been confirmed in the highest number of reports and
for which being a carrier plays an important role in their path-
ophysiology [31].
Interleukin-1 (IL-1)
Interleukin-1 (IL-1) plays a significant role in Th1 cell re-
sponse. It is produced by activated macrophages as well as
by cells outside the immune system such as keratinocytes. It
stimulates the production of other proinflammatory cytokines,
such as interferon gamma (INF-y), interleukin-6 (IL-6), and
tumor necrosis factor (TNF). IL-1 forms a cytokine family
composed of more than 10 subtypes: IL-1α, IL-1β, IL-1y
(IL-18), IL-1e, IL-1d, IL-1Ra, and IL-1H, of which IL-1β is
the most responsible for the proinflammatory effect [33].
Increased levels of IL-1 accompany various inflammatory
processes, which can increase the risk of IVH. A number of
earlier studies indicated the risk of IVH in infants born pre-
maturely from pregnancies complicated by chorioamnionitis
[19, 22]. The research by Viscardi et al. [34], where associa-
tion between the concentration of inflammatory markers in
umbilical cord or vein blood of an infant and the risk of neu-
rological abnormalities was investigated, has not confirmed
this relationship. The sample comprised 276 infants born be-
fore 33rd week of gestation with very low body weight at
birth. Significantly elevated levels of IL-1 in the blood serum
and cerebrospinal fluid (CSF) of these infants were associated
with intrauterine infections, compared to infants born from
pregnancies with no inflammatory response complications.
However, a straightforward relationship between intrauterine
infection/elevated IL-1 levels and the risk of abnormal neuro-
logic outcome, including IVH, was not observed. Similar re-
sults were found by Kaukola et al. [15] who investigated the
relationships of chorioamnionitis and levels of cord blood’s
proinflammatory cytokines with the presence of neurological
pathologies registered by cranial ultrasound scan (CUS) by
fourth week of life and neurological outcome assessed at the
corrected age of 24 months. The sample comprised 78 ex-
tremely low birth weight infants born before 32nd week of
gestation. They were classified into four groups, following the
results of histological tests of placenta (isolated histologic
chorioamnionitis (HCA), isolated placenta perfusion defect,
HCA and perfusion defect, no HCA or perfusion defect). No
significant differences between these groups were observed
for IL-1 blood serum levels.
Damage to the newborn’s brain may follow an intrauterine
infection that induced maternal and fetal immune response,
both systemic and localized to central nervous system
(CNS). Microorganisms and the mediators they produce stim-
ulate mononuclear cells to produce IL-1, and its elevated
levels increase the permeability of the blood-brain barrier, thus
facilitating the passage of these substances into the neonate’s
brain tissue [35]. Viscardi et al. [33] investigated associations
between the intrauterine presence of Ureaplasma parvum and
Ureaplasma urealyticum and the occurrence of IVH in a sam-
ple of 13 very low birth weight neonates born prematurely on
the 32nd week of gestation, of whom 74 had Ureaplasma
antigens in serum or cerebrospinal fluid. The analysis of both
cord and venous serum samples taken together demonstrated
significantly higher IL-1 levels in Ureaplasma PCR-positive
infants, compared to PCR-negative ones. However, the corre-
lation was not present when the analysis was done for cord
blood samples only, where increased levels of IL-1 were
found not only in 70% of seropositive infants but also in
almost half of the seronegative group. Correlation between
CSF cytokine levels and Ureoplasma sp. infection was not
observed. The incidence of IVH was evaluated on the basis
of a cranial ultrasound scan. For infants infected with
Ureaplasma sp., the risk of IVH III–IV increased 2.32-fold.
When the group included only the infants with increased se-
rum IL-1 levels, the risk was 5.36 times higher.
As demonstrated in the research into proinflammatory cy-
tokine polymorphisms, genetic factors have an impact on the
risk of IVH. A study by Ryckman et al. [24] included 271 very
low birth weight infants born before 32 weeks of gestation.
Ten genes potentially linked to increased IVH risk were iso-
lated and examined, with specific single nucleotide polymor-
phisms selected for these candidate genes, based on previous
research. A significant correlation was demonstrated only in
the case of IL-1β-31 gene polymorphism. Children with the
CT genotype or the IL-1β-31 C allele were at a higher risk for
IVH I-II and those with the CC genotype or the C allele, for
IVH III-IV, compared to children with the TT genotype or the
T allele. The IL-1β-31 C allele is associated with an increased
production of IL-1β in vivo. This may represent an evidence
that IL-1β plays a role in the pathophysiology of perinatal
brain injury. Increased levels of IL-1β are observed in the
amniotic fluid and/or cord blood of infants with IVH or
periventricular leukomalacia (PVL) [6].
Concentration of proinflammatory cytokines may also be
useful in predicting the complications of IVH. Following IVH
or posthemorrhagic hydrocephalus (PHH), many infants de-
velop white matter injuries (WMIs), resulting probably from
the adverse involvement of proinflammatory cytokines.
Correlations between concentration levels of specific cyto-
kines and the development of white matter damage have been
investigated by Schmitz et al. [28], in the paper cited in a
review paper by StephanieMerhar [20]. The studies show that
PHH neonates have increased levels of IL-1β in their CSF,
compared to the non-PHH control group, regardless of WMI.
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Savman et al., whose research is also cited in the paper, stud-
ied levels of cerebrospinal fluid cytokines in premature infants
with PHH and the correlations of these with periventricular
white matter injury, neurodevelopmental impairment, and the
need of intervention by insertion of a ventriculoperitoneal
shunt. Compared to the control group, increased CSF levels
of IL-1β, TNFα, IL-6, and IL-8 were found in preterm infants
with PHH. However, a relationship between the levels of these
cytokines and white matter lesions was not observed. This
would indicate that the presence of cytokines is a reaction to
the hemorrhage and does not reflect the severity of brain
damage.
Interleukin 6 (IL-6)
IL-6 is a cytokine with a very wide spectrum of action in the
areas including the development of the nervous and hemato-
poietic systems. It is an early marker of inflammation, a me-
diator of the acute phase response, and an activator of the
immune system, reaching its peak levels as early as 3–4 h after
pathogen stimulation. IL-6 levels rise also after mechanical
and thermal tissue damage. Its action is bidirectional: both
proinflammatory but also antiinflammatory (the latter by act-
ing against TNF-alpha and IL-1). It can cross the blood-brain
barrier [13].
Caldas et al. [8] studied IL-6 levels in umbilical cord blood
of 125 infants with very low birth weight, while the incidence
rate of IVHwas assessed through cranial ultrasound scans. No
statistically significant associations were found between IL-6
levels and IVH either. No correlations of this kind were found
by Bhandari et al. [7] in a study of 116 infants born between
weeks 23 and 34 of gestation either. Sorokin et al. [30] also
investigated the associations between umbilical cord blood
IL-6 levels and the risk of IVH in a group of 400 infants
(gestational age at birth 34.8 ± 3.8 weeks). Again, no signif-
icant correlation between IL-6 levels (>75 pc) and an in-
creased risk of IVH was observed. These studies confirmed
the impact of increased umbilical cord blood IL-6 levels on an
increased risk of a preterm delivery.
There is, however, an association between an increased risk
of IVH and prolonged premature rupture of membranes
(PPROM). The study by Hansen-Pupp et al. [12], concerning
correlations between cytokine levels and PPROM, IVH, and
WMI, included 74 infants born before 32 weeks of gestation.
Higher cord blood levels of IL-6 were observed in the group
of infants with maternal PPROM. Their IL-6 level peaked at
delivery, while in infants without PPROM, IL-6 peaked in the
arterial blood 6 h after birth. It then decreased in both groups
and stabilized at 72 h.
In the previously mentioned study by Kaukola et al. [15],
umbilical cord blood IL-6 levels were significantly elevated in
the group of infants with isolated HCA, compared to the group
with placenta perfusion defect and the group with neither
HCA nor perfusion defect. HCA, in turn, increased the risk
of IVH, mainly grades II and III. No direct association was
observed between cord blood IL-6 levels and the development
of IVH. Additionally, high level of IL-6 in umbilical cord
blood was highly predictive of the risk of premature birth. In
another study by Sarkar et al. [25], carried out on a group of 62
infants born before 28 weeks of gestation, HCAwas not found
to be associated with an increased risk of early onset IVH.
Goldenberg et al. [10] studied the frequency of umbilical
cord blood infections with U. urealyticum and Mycoplasma
hominis in preterm 23- to 32-week infants. He also evaluated
the associations of these infections with obstetric complica-
tions, markers of placental inflammation, and other patholog-
ical conditions in the newborn. The study included 351
mother-infant pairs. Bacteria were present in 23 % of infant
cord blood cultures which correlated with an increased inci-
dence of intrauterine infection and inflammation among these
infants. This was confirmed by an increased level of IL-6,
placental bacteria cultures, and placental histology.
Ureaplasma or Mycoplasma-positive infants were at higher
risk of developing systemic inflammatory response syndrome
(SIRS) and bronchopulmonary dysplasia (BPD), whereas an
increased incidence of other neonatal pathologies, such as
IVH, respiratory distress syndrome (RDS), or death, was not
observed.
The study by Heep et al. [13] investigated postnatal levels
of IL-6 in serum and brain injury shown in cranial ultrasound
scan and clinical symptoms in infants born before 28th week
of gestational age. The sample comprised of 88 infants
grouped according to the peak IL-6 level within 12 h of post-
natal age: <97 pc (≤100 pg/ml) and >97 pc (>100 pg/ml) of
healthy infants. IVH was present significantly more often
(63 % of infants) in the group with IL-6 levels above
100 pg/ml. In the group where IL-6 was below the concentra-
tion threshold, IVH occurred in 38 % of infants. Higher IL-6
levels were associated not only with a higher risk of IVH but
also with increased severity and higher neonatal morbidity at
<28 days after birth. These results allow the use of IL-6 as an
early marker of bleeding.
Pathogenesis of IVH may involve interactions between
proinflammatory cytokines and the coagulation system.
Vitamin K-dependent coagulation factors and infant serum
IL-6 levels were studied by Poralla et al. [23]. The study
sample comprised 132 extremely premature infants who were
divided into two groups: with IL-6 above and below 100 pg/
ml. Increased IL-6 levels were associated with decreased fac-
tor VII activity and increased concentration of fibrinogen.
These factors may play a role in IVH pathogenesis by causing
systemic and local hemodynamic changes and by damaging
the endothelium of cerebral vessels.
Research by Viscardi et al. [34] demonstrated that IL-6
levels in blood serum and cerebrospinal fluid of infants
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affected by maternal intrauterine infection were more of-
ten significantly elevated, compared to those of non-
affected babies. A correlation was demonstrated between
infant venous blood serum IL-6 levels and the presence of
abnormalities in CUS, but only in infants born after 28th
week of gestation. With regard to CSF, a similar correla-
tion was observed only in infants born before or in week
28 of gestational age.
The purpose of a research conducted by Satar et al.
[26] was to search for the association of the levels of
proinflammatory cytokines in maternal and cord blood at
birth with neonatal morbidity and mortality in the group
of infants with PPROM. The study group included 42
mother-infant pairs with PPROM, and the control group
comprised 41 pairs without PPROM. All infants were
born between weeks 29 and 35 of gestation. Maternal
serum levels of IL-6 in the group with PPROM were
significantly higher than in the control group, while a
similar correlation for cord blood was not found. Infants
born after PPROM had a higher risk of IVH, but a direct
association between increased IL-6 concentration and the
development of IVH was not demonstrated.
Sorokin et al. [29] investigated the association of ma-
ternal serum IL-6 levels with the risk of premature birth
and IVH development in infants. Samples were taken be-
tween weeks 24 and 32 of pregnancy from 475 patients
who carried a risk of premature delivery and had intact
membrane and who had received glucocorticoids
(betamethasone) 7–10 days before sample taking.
Mothers of infants born before week 32 had increased
levels of IL-6 in blood serum (>90 pc).
Göpel et al. [11] tested an earlier hypothesis that the IL-6-
174GG genotype is associated with increased susceptibility to
sepsis and the 174CC genotype is more common in preterm
infants with severe IVH. The study included 1206 premature-
ly born infants with birth weight below 1500 g. No significant
correlations were demonstrated between different IL-6-174
genotypes and grade IV IVH, leukomalacia, or infant death.
Interleukin 8 (IL-8)
IL-8 is a proinflammatory cytokine produced mainly not only
by macrophage cells but also by smooth muscle cells and
endothelial cells. It is also known as Bneutrophil chemotactic
factor,^ which describes one of the primary functions of this
cytokine. Besides, it also induces the process of phagocytosis
by the cells that arrived at the site of an inflammation. Carlo
et al. demonstrated the role of IL-8 in brain damage during the
processes of ischemia reperfusion, anoxia, and traumas.
Activated neutrophils accumulate in cerebral blood vessels,
thus obstructing microvascular perfusion and causing a re-
lease of various other proinflammatory mediators [9].
The associations of IL-8 levels in the newborn’s blood
with the occurrence of IVH and IVH-associated white
matter lesions (WMIs) were studied by Leviton et al.
[18]. One hundred twenty-three infants born before week
28 of gestation who had IVH but no WMI were compared
to a group of neonates with both IVH and WMI and a
control group of 677 healthy infants. Of all investigated
cytokines, elevated levels of IL-8 persisting for more than
1 day were most significantly associated with isolated
IVH as well as both IVH and WMI, compared to the
control group.
Increased levels of IL-8 in cord blood are associated with
PPROM and HCA, histologically diagnosed postpartum.
Both these conditions increase the risk of infant IVH, but no
direct association between IL-8 levels and a development of
IVH was demonstrated [15, 26].
Krediet et al. [16] investigated the relationship between
respiratory distress syndrome (RDS) and the risk of early vs.
late IVH (in the first 12 h of life vs. after 12 h). The levels of
proinflammatory cytokines in arterial blood were measured in
114 infants born before week 32 of gestation of whom 67were
diagnosed with RDS. Increased level of IL-8, induced by
RDS-related inflammation, increased the risk of early IVH
only. After 12 h of life, the level of IL-8 was still correlated
with RDS but had no impact on the development of late IVH.
Maternal intrauterine inflammation results also in an in-
flammatory response in the infant’s central nervous system.
In their research, Laborada and Nesin [17] evaluated whether
exposure to chorioamnionitis and fetal inflammatory syn-
drome was reflected in increased concentrations of selected
proinflammatory cytokines (TNF-alpha, IL-6, and IL-8) in the
cerebrospinal fluid of premature and term infants. The results
demonstrated a significant increase in IL-8 concentrations in
the CSF of neonates exposed to chorioamnionitis and
maternal/fetal inflammation.
Interleukin-18 (IL-18)
IL-18 is a proinflammatory cytokine that may mediate injuries
to the central nervous system. IL-18 is expressed in astrocytes
and microglia, and its receptor is found on astrocytes in the
periventricular area of the brain. Increased cord blood levels of
IL-18 are correlated with white matter damage and subsequent
development of cerebral palsy. Increased levels of IL-18 and
IL-1β in cerebrospinal fluid are associated with posthemor-
rhagic ventricular dilation [3].
Tumor necrosis factor (TNF-alpha)
TNF-alpha is a protein involved in the activation of the im-
mune system. This cytokine is produced mainly not only by
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activated macrophages but also by a variety of other cell types
such as lymphoid cells, mast cells, endothelial cells,
cardiomyocytes, adipocytes, connective tissue cells, and neu-
rons. It impacts various organ systems, with its biological
functions overlapping the functions of IL-6. It is a
chemoattractant for neutrophils and stimulates macrophages
for phagocytosis and production of both IL-1 and prostaglan-
din E2 (PGE2—which plays a role in the etiopathogenesis of
preterm birth). It can cause damage to microcirculatory endo-
thelium of the central nervous system, increasing the risk of
vessel rupture and IVH occurrence [31].
TNF may participate in the pathophysiology of
periventricular injury in several ways: by inducing fetal hypo-
tension and brain ischemia, by stimulating the production of a
tissue factor which then can activate the coagulation system
and lead to necrosis of white matter, by stimulating the pro-
duction of platelet-activating factor which can damage cell
membranes and cause direct brain cell damage, and by a direct
cytotoxic effect on oligodendrocytes.
Microbes and proinflammatory cytokines in peripheral
blood may, after crossing the blood-brain barrier which has
been weakened by inflammation, stimulate microglia to pro-
duce proinflammatory cytokines. They, in turn, can activate
the proliferation of astrocytes and production of TNF-alpha
which can cause damage to oligodendrocytes, the cells re-
sponsible for the deposition of myelin. Yoon et al. [35] tested
post mortem 17 brains of infants diagnosed with PVL and 17
controls. The expression of TNF-alpha, IL-1beta, or IL-6 was
found in 88 % of cases with PVL and in only 18 % of non-
PVL cases. Cytokines were present mainly in hypertrophic
astrocytes and microglial cells located in and around the ne-
crotic areas.
Vinukonda et al. [32] asked whether cyclooxygenase-2, its
derivative prostaglandin E2, prostanoid receptors, and proin-
flammatory cytokines (IL-1, TNF-alpha) were elevated in in-
traventricular hemorrhage and if their suppression confers
neuroprotection. They showed that cyclooxygenase-2, prosta-
noid receptor-1, or tumor necrosis factor-α inhibition reduced
inflammatory cell infiltration, apoptosis, neuronal degenera-
tion, and gliosis around the ventricles of studied pups with
intraventricular hemorrhage. Moreover, prostanoid receptor-
1 and tumor necrosis factor-α were downstream to
cyclooxygenase-2 in the inflammatory cascade induced by
intraventr icular hemorrhage. On the other hand,
cyclooxygenase-2-inhibition or suppression of downstream
molecules prostanoid receptor-1 or TNF-alpha might consti-
tute neuroprotective strategy for minimizing brain damage in
premature infants with intraventricular hemorrhage.
Conclusions from studies carried out on animal models may
contribute to similar methods being applied in prematurely
born infants with IVH, resulting in reduced mortality and neu-
rological complications in this group.
Viscardi et al. [34] investigated the association between the
concentration of inflammatory markers in CSF and the risk of
neurological abnormalities detected in CUS. The sample com-
prised 276 infants born before week 33 of gestation with very
low birth weight (<1501 g). Levels of TNF-alpha found in cere-
brospinal fluid of infantswith intrauterine infections did not differ
significantly from those found in infants born from pregnancies
not complicated by infection. At the same time, a positive corre-
lation of TNF-alphaCSF levels and abnormalities shown inCUS
was demonstrated, but only in infants born before or in week 28
of gestation. It is not possible, however, to conclude
unambigously whether increased TNF-alpha levels were a cause
Table 1 The overall significance of the selected cytokines in the pathogenesis of abnormalities in central nervous system
Cytokine Compartment Clinical significance and association with central nervous system abnormalities
IL-1β Infant’s vein blood serum No association with increased risk of abnormal neurological outcome (including IVH) [34]
Cerebrospinal fluid Association with increased risk of PHH, irrespective of coexistence of WMI [28].
Association with increased risk of PHH, but not with WMI [27]. No association
with increased risk of abnormal neurological outcome (including IVH) [34]
IL-6 Maternal vein blood serum No association with increased risk of IVH [26]
Umbilical cord blood No association with increased risk of IVH [7, 8, 10, 15, 30]
Infant’s vein blood serum Association with increased risk of IVH, its severity, and higher neonatal morbidity [13].
Association with abnormalities in CUS only in infants born after or in week 28
of gestational age [34]
Cerebrospinal fluid Association with increased risk of PHH, but not with WMI [27]. Association with
abnormalities in CUS only in infants born before or in week 28 of gestational age [34]
IL-8 Umbilical cord blood No association with IVH [15, 26]
Infant’s vein blood serum Association with isolated IVH and both IVH and WMI [18]
Cerebrospinal fluid Association with increased risk of PHH, but not with WMI [27]
IL-18 Cerebrospinal fluid Association with posthemorrhagic ventricular dilatation [3]
TNF-α Cerebrospinal fluid Association with abnormalities in CUS only in infants born before or in week 28
of gestational age [34]. Association with increased risk of PHH, but not with WMI [27]
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or an effect of damage to the central nervous system. The ultra-
sound scan was done after measuring cytokine levels in CSF.
In the case of TNF-alpha, genetic factors may play a role in
the risk of IVH. An important polymorphism occurs at position
308 in the TNF-alpha promoter region. Three variants exist:
homozygotic GG or AA and heterozygotic AG. The A allele
is responsible for strong and allele G for weak gene expression
in vitro. Previous research demonstrated an increased risk of
IVH in neonates with the TNF alfa-308 A allele. In a study
by Adcock et al., done on a sample of 178 newborn infants,
30% carried the A allele: 25%were heterozygotic (AG) and 5%
were homozygotic (AA). Homozygotic GG variant was found
in 70% of infants. Carriers of the A allele showed an increased
risk for IHV (grades I to IV), but when the group considered
included only grades III and IV, the association became not
significant [1]. Heep et al. [14] did a retrospective study on a
sample of 27 infants born before week 32 of pregnancy who
had severe IVH and a control group of 102 healthy infants, with
no IVH and born after week 32. Differences in the TNF-alpha
308 expression were not observed between the groups.
To summarize, the role of cytokines in pathogenesis of
IVH is complex, and the role of proinflammatory cyto-
kines is not fully known. It seems that concentrations of
specific cytokines in different compartments make it pos-
sible to assess the risk of premature birth, preterm rupture
of the membranes, and to determine an existing intrauter-
ine infection: Increased levels of IL-1 in the neonate’s
blood and the presence of certain polymorphisms correlate
with an increased risk of IVH in premature infants; in the
cerebrospinal fluid, IL-1 may also be a marker of existing
consequences of IVH, such as PHHC; increased levels of
IL-6 may be used for the assessment of the risk of pre-
mature delivery and intrauterine infection; measurement of
the levels of TNF-alpha and in the future administration of
TNF-alpha inhibitors may contribute to reducing adverse
neurological outcomes in infants who developed IVH. We
suggest that further analysis of the role of polymorphism
of selected cytokines should be performed. This could
probably make it possible to determine the group of new-
borns who are specifically at risk of developing IVH in
the perinatal period (Table 1).
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